Key result
Heart failure with coexisting atrial fibrillation is associated with increased risk of hospitalization and death, with AF incidence ranging from 5% in NYHA class I to 50% in NYHA class IV.
Why the study?
Does catheter ablation defer transplantation in patients with heart failure and atrial fibrillation?
Does catheter ablation defer transplantation in patients with heart failure and atrial fibrillation?
Discusses the potential role of catheter ablation for atrial fibrillation in patients with heart failure as a means to defer transplantation.
Patients with heart failure often have coexisting atrial fibrillation, and the incidence of atrial fibrillation is higher among patients with more advanced heart failure (ranging from 5% among those with New York Heart Association [NYHA] class I disease to 50% among those with NYHA class IV disease).1 The coexistence of heart failure and atrial fibrillation is associated with an increased risk of hospitalization and death.1 Atrial fibrillation may lead to neurohormonal activation, cardiac remodeling, inflammation, and tachycardia-mediated worsening of left ventricular function, and progression of heart failure can increase the incidence and burden of atrial fibrillation. Evidence for catheter ablation . . .
No takes yet. Share an insight, caveat, or question.
Eldrin F. Lewis (2023) conducted an editorial in Heart failure and atrial fibrillation. Catheter ablation was evaluated. Heart failure with coexisting atrial fibrillation is associated with increased risk of hospitalization and death, with AF incidence ranging from 5% in NYHA class I to 50% in NYHA class IV.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: